By expenditures
| Name | Title | Type |
|---|---|---|
| Tasha Booker | Chief Executive Officer | Auditee |
| Amy Hill | Assurance Senior Manager | Auditee |
| Lauren Willett | Assurance Manager | Auditee |
| Eric Karolak | CEO | Auditee |
| Tobin Perrill | Partner, Assurance & Advisory | Auditee |
| Rhonda Lasher | DIRECTOR OF FINANCE | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 351738 | 2024 | 2025-03-31 | Gbq Partners LLC | $16.61M |
| 295441 | 2023 | 2024-03-17 | Gbq Partners LLC | $14.25M |
| 264342 | 2022 | 2023-01-03 | Gbq Partners LLC | $5.55M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 351738 | 2024 | 2025-03-31 | 1123991 | 2024-005 | Significant Deficiency | - | L |
| 351738 | 2024 | 2025-03-31 | 1123990 | 2024-003 | Significant Deficiency | - | A |
| 351738 | 2024 | 2025-03-31 | 1123989 | 2024-005 | Significant Deficiency | - | L |
| 351738 | 2024 | 2025-03-31 | 1123988 | 2024-003 | Significant Deficiency | - | A |
| 351738 | 2024 | 2025-03-31 | 1123987 | 2024-005 | Significant Deficiency | - | L |
| 351738 | 2024 | 2025-03-31 | 1123986 | 2024-003 | Significant Deficiency | - | A |
| 351738 | 2024 | 2025-03-31 | 1123985 | 2024-005 | Significant Deficiency | - | L |
| 351738 | 2024 | 2025-03-31 | 1123984 | 2024-004 | Significant Deficiency | - | B |
| 351738 | 2024 | 2025-03-31 | 1123983 | 2024-003 | Significant Deficiency | - | A |
| 351738 | 2024 | 2025-03-31 | 1123982 | 2024-005 | Significant Deficiency | - | L |
| 351738 | 2024 | 2025-03-31 | 1123981 | 2024-004 | Significant Deficiency | - | B |
| 351738 | 2024 | 2025-03-31 | 1123980 | 2024-003 | Significant Deficiency | - | A |
| 351738 | 2024 | 2025-03-31 | 1123979 | 2024-005 | Significant Deficiency | - | L |
| 351738 | 2024 | 2025-03-31 | 1123978 | 2024-004 | Significant Deficiency | - | B |
| 351738 | 2024 | 2025-03-31 | 1123977 | 2024-003 | Significant Deficiency | - | A |
| 351738 | 2024 | 2025-03-31 | 547549 | 2024-005 | Significant Deficiency | - | L |
| 351738 | 2024 | 2025-03-31 | 547548 | 2024-003 | Significant Deficiency | - | A |
| 351738 | 2024 | 2025-03-31 | 547547 | 2024-005 | Significant Deficiency | - | L |
| 351738 | 2024 | 2025-03-31 | 547546 | 2024-003 | Significant Deficiency | - | A |
| 351738 | 2024 | 2025-03-31 | 547545 | 2024-005 | Significant Deficiency | - | L |
| 351738 | 2024 | 2025-03-31 | 547544 | 2024-003 | Significant Deficiency | - | A |
| 351738 | 2024 | 2025-03-31 | 547543 | 2024-005 | Significant Deficiency | - | L |
| 351738 | 2024 | 2025-03-31 | 547542 | 2024-004 | Significant Deficiency | - | B |
| 351738 | 2024 | 2025-03-31 | 547541 | 2024-003 | Significant Deficiency | - | A |
| 351738 | 2024 | 2025-03-31 | 547540 | 2024-005 | Significant Deficiency | - | L |
| 351738 | 2024 | 2025-03-31 | 547539 | 2024-004 | Significant Deficiency | - | B |
| 351738 | 2024 | 2025-03-31 | 547538 | 2024-003 | Significant Deficiency | - | A |
| 351738 | 2024 | 2025-03-31 | 547537 | 2024-005 | Significant Deficiency | - | L |
| 351738 | 2024 | 2025-03-31 | 547536 | 2024-004 | Significant Deficiency | - | B |
| 351738 | 2024 | 2025-03-31 | 547535 | 2024-003 | Significant Deficiency | - | A |